HK Stock MarketDetailed Quotes
02197 CLOVER BIO-B
- 0.300
- -0.015-4.76%
Not Open Nov 6 16:08 CST
389.12MMarket Cap-401P/E (TTM)
0.310High0.300Low2.15MVolume0.310Open0.315Pre Close651.21KTurnover0.17%Turnover RatioLossP/E (Static)1.30BShares0.79052wk High-0.43P/B389.12MFloat Cap0.20152wk Low--Dividend TTM1.30BShs Float14.800Historical High--Dividend LFY3.18%Amplitude0.201Historical Low0.302Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
CLOVER BIO-B Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | -4,029.96%-10.1M | --39.26M | --257K | ---- | ---- | ---- | ---- | ---- |
| Operating income | -4,029.96%-10.1M | 39.26M | 257K | |||||
| Cost of sales | 974.75%1.77M | ---15.01M | ---202K | ---- | ---- | ---- | ---- | ---- |
| Operating expenses | 974.75%1.77M | -15.01M | -202K | |||||
| Gross profit | -15,250.91%-8.33M | 24.24M | 55K | |||||
| Selling expenses | 70.31%-6.68M | ---54.77M | ---22.51M | ---- | ---- | ---- | ---- | ---- |
| Administrative expenses | 61.56%-42.08M | 51.54%-198.82M | 51.42%-109.47M | -18.67%-410.24M | ---225.34M | -352.33%-345.71M | -348.66%-76.43M | ---17.04M |
| Research and development expenses | 74.51%-98.3M | 55.65%-649.89M | 54.91%-385.6M | 19.77%-1.47B | ---855.27M | -700.24%-1.83B | -398.31%-228.22M | ---45.8M |
| Revaluation surplus | ---- | ---- | ---- | ---- | ---- | -537.09%-3.81B | -6,564.67%-597.66M | --9.25M |
| -Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | -537.09%-3.81B | -6,564.67%-597.66M | --9.25M |
| Special items of operating profit | -94.52%64.61M | 233.13%759.41M | 2,313.70%1.18B | -1,905.81%-570.41M | ---53.3M | -273.30%-28.44M | -149.67%-7.62M | --15.34M |
| Operating profit | -113.71%-90.78M | 95.10%-119.82M | 158.42%662.37M | 59.29%-2.45B | -1.13B | -560.28%-6.01B | -2,278.83%-909.93M | -38.25M |
| Financing cost | 63.04%-4.34M | -215.73%-18.72M | -439.69%-11.75M | 27.82%-5.93M | ---2.18M | -176.35%-8.22M | 71.23%-2.97M | ---10.33M |
| Earning before tax | -114.62%-95.12M | 94.35%-138.54M | 157.27%650.62M | 59.25%-2.45B | -1.14B | -559.03%-6.02B | -1,779.05%-912.9M | -48.58M |
| After-tax profit from continuing operations | -114.62%-95.12M | 94.35%-138.54M | 157.27%650.62M | 59.25%-2.45B | -1.14B | -559.03%-6.02B | -1,779.05%-912.9M | -48.58M |
| Earning after tax | -114.62%-95.12M | 94.35%-138.54M | 157.27%650.62M | 59.25%-2.45B | -1.14B | -559.03%-6.02B | -1,779.05%-912.9M | -48.58M |
| Profit attributable to shareholders | -114.62%-95.12M | 94.35%-138.54M | 157.27%650.62M | 59.25%-2.45B | -1.14B | -559.03%-6.02B | -1,779.05%-912.9M | -48.58M |
| Basic earnings per share | -115.38%-0.08 | 95.05%-0.11 | 149.52%0.52 | 82.95%-2.22 | -1.05 | -398.85%-13.02 | -169.07%-2.61 | -0.97 |
| Diluted earnings per share | -115.38%-0.08 | 95.05%-0.11 | 149.52%0.52 | 82.95%-2.22 | -1.05 | -398.85%-13.02 | -169.07%-2.61 | -0.97 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data